PMID: 19147430Jan 17, 2009Paper

Molecular mechanisms of action of some immunosuppressive drugs

Medicina
Ana C LibermanEduardo Arzt

Abstract

A number of natural and synthetic substances are used in the treatment of immunological disorders. The immunosuppressive drugs are widely utilized in clinical treatments of autoimmune disorders, in the prevention of transplant rejection as well as in non-autoimmune diseases such as allergy. The design of immunosuppressive therapies is based on the control of the exacerbated immune response. The pathophysiologic mean of this concept is to modulate the action of mononuclear cells, being T cells the main targets. Immunosuppressive agents have different molecular targets, and an important drawback in their use is that they also inhibit the normal immune system response. Depending on their mode of action, immunosuppressive drugs can be classified in four different groups: antinflammatory drugs of the corticosteroid family, inhibitors of the calcineurin pathway, cytototoxic or antiproliferative drugs and specific antibodies. In this article, we focus on the molecular action of immunosuppressive drugs such as steroids, cyclosporine, tacrolimus, azathioprine, cyclophosphamide, sirolimus, mycophenolate mofetil, leflunomide and specific antibodies, providing data to characterize and improve the use of these agents.

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Nederlands tijdschrift voor geneeskunde
R J ten Berge, P T Schellekens
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
M SuthanthiranT B Strom
Journal of Nephrology
Michael Fischereder, Matthias Kretzler
Current Drug Targets. Cardiovascular & Haematological Disorders
Anlun Ma, Huifang Chen
© 2021 Meta ULC. All rights reserved